Description:

SOUTHWEST ONCOLOGY GROUP Post-Consolidation Adverse Event Summary Form: Maintenance Chemotherapy (S0521) Combination Chemotherapy With or Without Gemtuzumab Followed By Tretinoin, Mercaptopurine, and Methotrexate or Observation in Treating Patients With Acute Promyelocytic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DFCC65-BC50-09BA-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=02DFCC65-BC50-09BA-E044-0003BA3F9857

Keywords:
Versions (4) ▾
  1. 9/19/12
  2. 1/8/15
  3. 1/9/15
  4. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Leukemia NCT00492856 Toxicity - SOUTHWEST ONCOLOGY GROUP Post-Consolidation Adverse Event Summary Form: Maintenance Chemotherapy (S0521) - 2416541v1.0

No Instruction available.

  1. StudyEvent: SOUTHWEST ONCOLOGY GROUP Post-Consolidation Adverse Event Summary Form: Maintenance Chemotherapy (S0521)
    1. No Instruction available.
Header
Participating Group Name
Adverse Events
Were adverse events assessed during this report period?
CTC Adverse Event Term
CTC AE Attribution Code
Comments

Similar models